Natural History of Benign Thyroid Nodules
Interview with Sebastiano Filetti, MD, author of The Natural History of Benign Thyroid Nodules (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - March 3, 2015 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Inside Oncology: Lenvatinib and Lenalidomide Approved, New Agent Promising in Myeloma, and More
Approval of lenvatinib for differentiated thyroid cancer, the approval of frontline lenalidomide and positive findings for ixazomib in multiple myeloma, and a newly launched oncology care model by Med...
Author: onclivetv
Added: 02/25/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 25, 2015 Category: Cancer & Oncology Source Type: podcasts
Living With Thyroid Cancer: The RAI-Refractory Patient
It is true a majority of thyroid cancer patients are cured, there are some who are not. The patients in this episode learn that the their cancer is not like the others. We meet Dr. Marcia Brose, the...
Author: vitaloptions
Added: 02/17/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 18, 2015 Category: Cancer & Oncology Source Type: podcasts
New drug shows improvement in survival of advanced thyroid cancer
In a pivotal Phase III study led by researchers at The University of Texas MD Anderson Cancer Center, the oral anti-angiogenic therapy lenvatinib has shown dramatic improvement in progression-free sur...
Author: mdanderson
Added: 02/11/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 11, 2015 Category: Cancer & Oncology Source Type: podcasts
Living With Thyroid Cancer: After Surgery Follow-up Care
Surgeons, doctors and professionals discuss the many aspects of thyroid surgery aftercare, including who is involved (it's not just the surgeons!), what to expect as far as after-surgery symptoms to w...
Author: vitaloptions
Added: 02/10/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 11, 2015 Category: Cancer & Oncology Source Type: podcasts
Living With Thyroid Cancer: Voice Changes
While some temporary voice changes due to swelling post-operatively is normal, roughly 1-2% of thyroidectomy patients experience some form of permanent voice change. While the chances are rare, it's i...
Author: vitaloptions
Added: 02/10/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 11, 2015 Category: Cancer & Oncology Source Type: podcasts
Living With Thyroid Cancer: Surgery
While surgery is common in the treatment plan for those diagnosed with thyroid cancer, the surgery types, lengths and risks can vary greatly depending on the specific individual. Some are able to have...
Author: vitaloptions
Added: 02/10/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 11, 2015 Category: Cancer & Oncology Source Type: podcasts
Living With Thyroid Cancer: There Is No Such Thing As Good Cancer
Cancer. No single word causes greater fear. Upon hearing the words, “You have cancer,” many thyroid cancer patients are told not to worry because they have the “good” cancer. Is it the best practice...
Author: vitaloptions
Added: 02/10/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 11, 2015 Category: Cancer & Oncology Source Type: podcasts
Living With Thyroid Cancer: Oral Issues - Dry Mouth
Featuring Tracy Rode (thyroid cancer survivor), Richard Cardoso, DDS, MS (University of Texas MD Anderson Cancer Center), and Steven I. Sherman, MD (University of Texas MD Anderson Cancer Center).
Author: vitaloptions
Added: 02/10/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 11, 2015 Category: Cancer & Oncology Source Type: podcasts
Living with Thyroid Cancer: Series Overview
Receiving a diagnosis of thyroid cancer can be a frightening challenge. It can be difficult to know what to expect, where to go for help and support, and how and where to find the best information. Th...
Author: vitaloptions
Added: 02/06/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 7, 2015 Category: Cancer & Oncology Source Type: podcasts
Cabozantinib for Late Stage Kidney Cancer
Cometriq (cabozantinib) is already approved for thyroid cancer and is showing promise for late stage kidney cancer.
GRACEcast 259 Kidney
Author: cancergrace
Added: 08/13/2014 (Source: Oncology Tube)
Source: Oncology Tube - August 13, 2014 Category: Cancer & Oncology Source Type: podcasts
Thyroid cancer is on the rise
Download from iTunes: https://itunes.apple.com/us.... The number of thyroid cancer cases is growing each year and it's unclear why. In the Un...
Author: mdanderson
Added: 06/16/2014 (Source: Oncology Tube)
Source: Oncology Tube - June 16, 2014 Category: Cancer & Oncology Source Type: podcasts
Status and Potential Utility of Cabozantinib in Lung Cancer?
http://cancerGRACE.org/...
Dr. Heather Wakelee of Stanford University Medical Center discusses whether or not cabozantinib - a drug already approved for thyroid cancer - can help patients with lung ca...
Author: cancergrace
Added: 05/20/2014 (Source: Oncology Tube)
Source: Oncology Tube - May 20, 2014 Category: Cancer & Oncology Source Type: podcasts
Marcia Brose, MD, PhD - Assessing the Clinical Potential of Emerging Targeted Agents in Advanced, Differentiated Thyroid Cancer
Assessing the Clinical Potential of Emerging Targeted Agents in Advanced, Differentiated Thyroid Cancer (Source: PeerView CME/CE Audio Podcast - Oncology)
Source: PeerView CME/CE Audio Podcast - Oncology - May 1, 2014 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
The Lancet: April 24, 2014
Marcia Brose discusses results of a phase III trial of the kinase inhibitor sorafenib for treating radioactive iodine-refractory thyroid cancer. (Source: Listen to The Lancet)
Source: Listen to The Lancet - April 24, 2014 Category: General Medicine Authors: The Lancet Source Type: podcasts
